New Zealand Official CrestGazette.govt.nz
Advanced search
Find a specific notice:
Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:

Ilaris
Canakinumab 150mg
Powder for injection
Novartis New Zealand Limited
Novartis Pharma Stein AG, Stein, Switzerland
Hameln Pharmaceuticals GmbH, Hameln, Germany

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Stivarga
Regorafenib monohydrate 41.49mg equivalent to Regorafenib 40mg
Tablet
Bayer New Zealand Limited
Bayer Pharma AG, Leverkusen, Germany

Dated this 12th day of March 2015.

SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Publication Date
19 Mar 2015

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2015-go1553

Issue Number

26
Title
View PDF
Description
Principal Edition, 19 March 2015
File Type and Size
PDF (20 KB)
Page Number 0